Unknown

Dataset Information

0

Albendazole-Induced SIRT3 Upregulation Protects Human Leukemia K562 Cells from the Cytotoxicity of MCL1 Suppression.


ABSTRACT: Previous studies have shown that MCL1 stabilization confers cancer cells resistance to microtubule targeting agents (MTAs) and functionally extends the lifespan of MTA-triggered mitotically arrested cells. Albendazole (ABZ), a benzimidazole anthelmintic, shows microtubule-destabilizing activity and has been repositioned for cancer therapies. To clarify the role of MCL1 in ABZ-induced apoptosis, we investigated the cytotoxicity of ABZ on human leukemia K562 cells. Treatment with ABZ for 24 h did not appreciably induce apoptosis or mitochondrial depolarization in K562 cells, though it caused the mitotic arrest of K562 cells. ABZ-evoked p38 MAPK activation concurrently suppressed Sp1-mediated MCL1 expression and increased SIRT3 mRNA stability and protein expression. ABZ and A-1210477 (an MCL1 inhibitor) enhanced the cytotoxicity of ABT-263 (a BCL2/BCL2L1 inhibitor) to their effect on MCL1 suppression. Unlike ABZ, A-1210477 did not affect SIRT3 expression and reduced the survival of K562 cells. Overexpression of SIRT3 attenuated the A-1210477 cytotoxicity on K562 cells. ABZ treatment elicited marked apoptosis and ??m loss in ABT-263-resistant K562 (K562/R) cells, but did not alter SIRT3 expression. Ectopic expression of SIRT3 alleviated the cytotoxicity of ABZ on K562/R cells. Collectively, our data demonstrate that ABZ-induced SIRT3 upregulation delays the apoptosis-inducing effect of MCL1 suppression on apoptosis induction in K562 cells.

SUBMITTER: Wang LJ 

PROVIDER: S-EPMC7312678 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Albendazole-Induced SIRT3 Upregulation Protects Human Leukemia K562 Cells from the Cytotoxicity of MCL1 Suppression.

Wang Liang-Jun LJ   Liou Li-Ren LR   Shi Yi-Jun YJ   Chiou Jing-Ting JT   Lee Yuan-Chin YC   Huang Chia-Hui CH   Huang Po-Wei PW   Chang Long-Sen LS  

International journal of molecular sciences 20200530 11


Previous studies have shown that MCL1 stabilization confers cancer cells resistance to microtubule targeting agents (MTAs) and functionally extends the lifespan of MTA-triggered mitotically arrested cells. Albendazole (ABZ), a benzimidazole anthelmintic, shows microtubule-destabilizing activity and has been repositioned for cancer therapies. To clarify the role of MCL1 in ABZ-induced apoptosis, we investigated the cytotoxicity of ABZ on human leukemia K562 cells. Treatment with ABZ for 24 h did  ...[more]

Similar Datasets

| S-EPMC2877934 | biostudies-literature
| S-EPMC7221302 | biostudies-literature
2016-08-25 | E-GEOD-79224 | biostudies-arrayexpress
| S-EPMC9276754 | biostudies-literature
| S-EPMC3434662 | biostudies-literature
| S-EPMC8881882 | biostudies-literature
| S-EPMC8451577 | biostudies-literature
| S-EPMC8137540 | biostudies-literature
| S-EPMC7930742 | biostudies-literature
2020-12-28 | GSE131912 | GEO